A Comparative Clinical Study to evaluate the efficacy of vangashilajatu and nishaamalaki in the management of Madhumeha(Type 2 Diabetes Mellitus)

An Open Labelled Parallel Comparative Clinical Study to evaluate the efficacy of Vangashilajatu and Nishaamalaki in the management of Madhumeha with special reference to Type 2 Diabetes Mellitus. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070739

Enrollment

Registered

2024-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E08-E13- Diabetes mellitus

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Willing for clinical trials and ready to give written consent. 2.Patients with age between 25-60 years of either sex. 3.Patients possessing signs and symptoms of Prameha (Diabetes Mellitus). 4.Freshly diagnosed & confirmed cases of Madhumeha on the basis of Diagnostic criteria for diabetes. 5.FBS-126-200 mg/dl and PPBS-200-300 mg/dl 6. HbA1c 6.5%-8%

Exclusion criteria

Exclusion criteria: 1. Patients not willing for the clinical trail. 2. Patients not fulfilling the inclusion criteria 3. Patients below the age of 25 years and above the age of 60 years. 4. Fasting blood sugar level less than 126mg/dl and greater than 200 mg/dl, post prandial blood sugar level less than 200mg/dl and greater than 300 mg/dl, HbA1C less than 6.5 percentage and greater than 8 percentage 5. Insulin dependent Diabetes mellitus(IDDM), gestational Diabetes, MODY, LADA. 6. Endocrinopathies. 7. Pregnant ladies and lactating mothers

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of Vangashilajatu in comparison to Nishaamlaki by applying appropriate statistical tools in the management of MadhumehaTimepoint: 28 days	—

Secondary

Measure	Time frame
1- Reduction in scoring pattern of sign and symptoms of Madhumeha 2- Improvement and management of blood sugar level and other hematological parameters 3- Help to live diabetic patients without complicationsTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Himani Bhardwaj

Institute for Ayurved Studies and Research

mehranilam@gmail.com9671368058

Outcome results